2024 Q3 Form 10-Q Financial Statement

#000173112224001273 Filed on August 16, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $75.79K $52.96K
YoY Change -40.63% -72.22%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $198.6K $176.1K
YoY Change -37.43% -47.36%
Operating Profit -$198.6K -$176.1K
YoY Change -37.43% -49.96%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net $6.475M $1.223M
YoY Change 2184.37% -112.78%
Pretax Income $6.276M $1.046M
YoY Change -18567.79% -110.55%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings $6.284M $1.048M
YoY Change -8759.65% -110.58%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 16.81B shares 16.81B shares
Diluted Shares Outstanding 27.63B shares 69.41B shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.05K $35.01K
YoY Change -71.74% -38.12%
Cash & Equivalents $1.505K $6.131K
Short-Term Investments $9.546K $28.88K
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $57.30K $81.26K
YoY Change -76.11% -77.09%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $57.30K $81.26K
Total Long-Term Assets $0.00 $0.00
Total Assets $57.30K $81.26K
YoY Change -76.11% -77.09%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $790.0K $775.0K
YoY Change -30.91% -24.68%
Accrued Expenses $0.00 $0.00
YoY Change -100.0% -100.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $5.973M
YoY Change -13.87%
Total Short-Term Liabilities $16.09M $22.40M
YoY Change -47.35% -27.85%
LONG-TERM LIABILITIES
Long-Term Debt $328.8K
YoY Change 5.79%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $328.7K $328.7K
YoY Change 5.29% 5.79%
TOTAL LIABILITIES
Total Short-Term Liabilities $16.09M $22.40M
Total Long-Term Liabilities $328.7K $328.7K
Total Liabilities $16.42M $22.73M
YoY Change -46.81% -27.52%
SHAREHOLDERS EQUITY
Retained Earnings -$301.5M -$307.8M
YoY Change -4.24% -2.25%
Common Stock $168.1K $168.1K
YoY Change 143.54% 202.9%
Preferred Stock
YoY Change
Treasury Stock (at cost) $11.06K $11.06K
YoY Change -98.28% -98.28%
Treasury Stock Shares
Shareholders Equity -$15.31M -$21.60M
YoY Change
Total Liabilities & Shareholders Equity $57.30K $81.26K
YoY Change -76.11% -77.09%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $6.284M $1.048M
YoY Change -8759.65% -110.58%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $22.46K
YoY Change -121.48%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -16.50K
YoY Change -118.42%
NET CHANGE
Cash From Operating Activities 22.46K
Cash From Investing Activities
Cash From Financing Activities -16.50K
Net Change In Cash 5.960K
YoY Change -139.76%
FREE CASH FLOW
Cash From Operating Activities $22.46K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
CY2023Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
315297 usd
CY2024Q2 GTCH Change In Fair Value Of Marketable Securities
ChangeInFairValueOfMarketableSecurities
-1500 usd
CY2023Q2 GTCH Change In Fair Value Of Marketable Securities
ChangeInFairValueOfMarketableSecurities
-4855 usd
GTCH Change In Fair Value Of Marketable Securities
ChangeInFairValueOfMarketableSecurities
669 usd
GTCH Change In Fair Value Of Marketable Securities
ChangeInFairValueOfMarketableSecurities
3692 usd
CY2024Q2 GTCH Other Income Related Party Licensing Income
OtherIncomeRelatedPartyLicensingIncome
0 usd
CY2023Q2 GTCH Other Income Related Party Licensing Income
OtherIncomeRelatedPartyLicensingIncome
9586 usd
GTCH Other Income Related Party Licensing Income
OtherIncomeRelatedPartyLicensingIncome
0 usd
GTCH Other Income Related Party Licensing Income
OtherIncomeRelatedPartyLicensingIncome
203212 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1222574 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-9570575 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
8560088 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-14737005 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1046496 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-9874528 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8206384 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15507091 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
1046496 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-9874528 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
8206384 usd
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-15507091 usd
CY2024Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
0 usd
CY2023Q2 us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-41235 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
0 usd
us-gaap Discontinued Operation Gain Loss On Disposal Of Discontinued Operation Net Of Tax
DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax
-38385 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
1046496 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
-9915763 usd
us-gaap Profit Loss
ProfitLoss
8206384 usd
us-gaap Profit Loss
ProfitLoss
-15545476 usd
CY2024Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-9254 usd
CY2023Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-6741 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-11354 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
43614 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
1048224 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-9909022 usd
us-gaap Net Income Loss
NetIncomeLoss
8210212 usd
us-gaap Net Income Loss
NetIncomeLoss
-15589090 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15982171236 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5161471785 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15982171236 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
3392096025 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69406539967 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28485320260 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69406539967 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
26715944500 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-32110382 usd
CY2024Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
557561 usd
CY2024Q1 GTCH Fair Value Of Derivative Liability Due To Conversions
FairValueOfDerivativeLiabilityDueToConversions
694919 usd
CY2024Q1 GTCH Tokenize Investment Reclassification
TokenizeInvestmentReclassification
-1660 usd
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7159889 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-23699672 usd
CY2024Q2 GTCH Visionwave Investment Reclassification
VisionwaveInvestmentReclassification
1000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
1046496 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-22652180 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-18830908 usd
CY2023Q1 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
403548 usd
CY2023Q1 GTCH Fair Value Of Derivative Liability Due To Conversions
FairValueOfDerivativeLiabilityDueToConversions
316223 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
80000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-5629713 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-23660850 usd
CY2023Q2 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
881372 usd
CY2023Q2 GTCH Fair Value Of Derivative Liability Due To Conversions
FairValueOfDerivativeLiabilityDueToConversions
1686461 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-9833571 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-30926588 usd
us-gaap Profit Loss
ProfitLoss
8206384 usd
us-gaap Profit Loss
ProfitLoss
-15545476 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
43347 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
268423 usd
GTCH Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
-8750797 usd
GTCH Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
13028486 usd
GTCH Excess Of Debt Discount And Financing Costs
ExcessOfDebtDiscountAndFinancingCosts
0 usd
GTCH Excess Of Debt Discount And Financing Costs
ExcessOfDebtDiscountAndFinancingCosts
1528816 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
80000 usd
GTCH Change In Fair Value Of Marketable Security
ChangeInFairValueOfMarketableSecurity
669 usd
GTCH Change In Fair Value Of Marketable Security
ChangeInFairValueOfMarketableSecurity
3692 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 usd
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
315297 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
10292 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-0 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-1259 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-0 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
39500 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-0 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1291 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-0 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
452 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-48921 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
0 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-5000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-403157 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
838357 usd
GTCH Increase Decrease In Accounts Payable And Accrued Liabilities Rp
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRP
936702 usd
GTCH Increase Decrease In Accounts Payable And Accrued Liabilities Rp
IncreaseDecreaseInAccountsPayableAndAccruedLiabilitiesRP
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33148 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-217196 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 usd
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
92150 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
27546 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
-0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
-0 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
549564 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
-0 usd
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
59004 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
578893 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
92150 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-27546 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
154625 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5602 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-62571 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
529 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
106639 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6131 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
44068 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
GTCH Reduction In Derivative Liability Due To Conversion
ReductionInDerivativeLiabilityDueToConversion
694919 usd
GTCH Reduction In Derivative Liability Due To Conversion
ReductionInDerivativeLiabilityDueToConversion
63379 usd
GTCH Shares Issued For Conversion Of Convertible Debt
SharesIssuedForConversionOfConvertibleDebt
557560 usd
GTCH Shares Issued For Conversion Of Convertible Debt
SharesIssuedForConversionOfConvertibleDebt
2002684 usd
GTCH Debt Discount Related To Convertible Debt
DebtDiscountRelatedToConvertibleDebt
0 usd
GTCH Debt Discount Related To Convertible Debt
DebtDiscountRelatedToConvertibleDebt
1284920 usd
GTCH Visionwave Investment Reclassifications
VisionwaveInvestmentReclassifications
24856 usd
GTCH Visionwave Investment Reclassifications
VisionwaveInvestmentReclassifications
0 usd
GTCH Tokenize Investment Reclassifications
TokenizeInvestmentReclassifications
1660 usd
GTCH Tokenize Investment Reclassifications
TokenizeInvestmentReclassifications
0 usd
CY2021Q4 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1 for 50
CY2024Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2024Q2 us-gaap Common Unit Authorized
CommonUnitAuthorized
10000000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000000 shares
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307775556 usd
CY2024Q2 GTCH Working Capital Deficit
WorkingCapitalDeficit
22323432 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zWde5rBhIvRg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_86C_zGJttsbPaTmi">Use of Estimates</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying condensed consolidated financial statements include valuation of derivatives and valuation allowance on deferred tax assets.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
0 usd
CY2023Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
0 usd
us-gaap Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
<p id="xdx_84F_eus-gaap--DerivativesReportingOfDerivativeActivity_z4hOy0EFLa32" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><span id="xdx_862_zmQca0U7ziud">Derivative Financial Instruments</span></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates all of its agreements to determine if such instruments have derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its FV and is then re-valued at each reporting date, with changes in the FV reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a weighted-average Black-Scholes-Merton option pricing model to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. As of June 30, 2024 and December 31, 2023, the Company’s only derivative financial instrument was an embedded conversion feature associated with convertible notes payable due to certain provisions that allow for a change in the conversion price based on a percentage of the Company’s stock price at the date of conversion.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 GTCH Conversion Feature On Convertible Notes
ConversionFeatureOnConvertibleNotes
4670346 usd
CY2023Q4 GTCH Conversion Feature On Convertible Notes
ConversionFeatureOnConvertibleNotes
14116062 usd
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p id="xdx_847_eus-gaap--PriorPeriodReclassificationAdjustmentDescription_zPvpoKKUA1Bd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_862_zhtor8fuxRSd">Reclassification</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Effective July 1, 2023, the Company terminated its joint venture revenue sharing (“Termination Agreement”) with Mahaser LTD (“Mahaser”). Until June 30, 2023, the Company’s variable interests in Mahaser obligate the Company to absorb deficits and provide it with the right to receive benefits that could potentially be significant to Mahaser. The Company evaluated for the period ended on June 30, 2023, whether it has a variable interest in Mahaser, whether Mahaser is a VIE and whether the Company has a controlling financial interest in Mahaser. The Company concluded that it has variable interests in Mahaser on the basis of GBT has 100% control over the JV/revenue sharing, and as such should consolidate the JV into its books and records as it assigned 100% financial responsibility. Mahaser’s equity at risk, as defined by GAAP, is considered to be insufficient to finance its activities without additional support, and, therefore, Mahaser is considered a VIE. As termination Agreement took place during the reporting period, the financial been classified to disclose this operation as discontinued operation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022Q1 us-gaap Debt Instrument Annual Principal Payment
DebtInstrumentAnnualPrincipalPayment
200000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
69406539967 shares
CY2023 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
75975606634 shares
CY2024Q2 us-gaap Marketable Securities
MarketableSecurities
28877 usd
CY2023Q4 us-gaap Marketable Securities
MarketableSecurities
29546 usd
CY2024Q2 GTCH Stock Loan Receivable
StockLoanReceivable
-7610147 usd
CY2023Q4 GTCH Stock Loan Receivable
StockLoanReceivable
-7610147 usd
GTCH Note Payable Description
NotePayableDescription
Note payable by Gopher Protocol Costa Rica Sociedad De Responsabilidad Limitada to the Company in the principal amount of $5,000,000 dated February 6, 2019 (of which the underlying security for this Promissory Note is 30,000,000 restricted shares of common stock of Mobiquity Technologies, Inc. (“Mobiquity”) and 60,000,000 restricted shares of common stock of Mobiquity.
CY2020Q1 GTCH Services Payable
ServicesPayable
33333 usd
CY2020Q1 GTCH Impairment Charge
ImpairmentCharge
5500000 usd
CY2021Q4 GTCH Impairment Charge
ImpairmentCharge
15400000 usd
CY2024Q2 us-gaap Investments
Investments
0 usd
CY2023Q4 us-gaap Investments
Investments
0 usd
CY2024Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
775043 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
773974 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
0 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
499492 usd
CY2024Q2 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4192763 usd
CY2023Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
4099380 usd
CY2024Q2 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
4967807 usd
CY2023Q4 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
5372846 usd
CY2024Q2 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
659000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
490000 usd
CY2024Q2 us-gaap Accrued Liabilities Fair Value Disclosure
AccruedLiabilitiesFairValueDisclosure
4100000 usd
CY2024Q2 GTCH Accounts Payable Related Parties
AccountsPayableRelatedParties
980000 usd
CY2023Q4 GTCH Accounts Payable Related Parties
AccountsPayableRelatedParties
770000 usd
CY2024Q2 GTCH Accrued Interest Related Parties
AccruedInterestRelatedParties
1723413 usd
CY2023Q4 GTCH Accrued Interest Related Parties
AccruedInterestRelatedParties
96115 usd
CY2024Q2 GTCH Other Payables Related Parties
OtherPayablesRelatedParties
1595814 usd
CY2023Q4 GTCH Other Payables Related Parties
OtherPayablesRelatedParties
901595 usd
CY2024Q2 GTCH Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
2703413 usd
CY2023Q4 GTCH Accounts Payable And Accrued Expenses Related Party Current
AccountsPayableAndAccruedExpensesRelatedPartyCurrent
1767710 usd
CY2024Q2 GTCH Accounts Payable Related Parties
AccountsPayableRelatedParties
980000 usd
CY2024Q2 GTCH Other Payable Related Parties
OtherPayableRelatedParties
1600000 usd
CY2024Q2 us-gaap Convertible Debt
ConvertibleDebt
5323076 usd
CY2023Q4 us-gaap Convertible Debt
ConvertibleDebt
5708756 usd
CY2024Q2 GTCH Debt Instruments Unamortized Discount Noncurrent
DebtInstrumentsUnamortizedDiscountNoncurrent
-2656 usd
CY2023Q4 GTCH Debt Instruments Unamortized Discount Noncurrent
DebtInstrumentsUnamortizedDiscountNoncurrent
-43739 usd
CY2024Q2 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
5320420 usd
CY2023Q4 us-gaap Other Notes Payable Current
OtherNotesPayableCurrent
5665017 usd
CY2024Q2 GTCH Less Current Portion
LessCurrentPortion
5320420 usd
CY2023Q4 GTCH Less Current Portion
LessCurrentPortion
5665017 usd
CY2024Q2 GTCH Convertible Notes Payable Longterm Portion
ConvertibleNotesPayableLongtermPortion
0 usd
CY2023Q4 GTCH Convertible Notes Payable Longterm Portion
ConvertibleNotesPayableLongtermPortion
0 usd
CY2021 GTCH Charge Related To Modification Of Debt
ChargeRelatedToModificationOfDebt
13777480 usd
GTCH Convertible Note Payable Description
ConvertibleNotePayableDescription
IGOR 1 converted $195,500 of the convertible note into 2,300,000,000 shares of the Company’s common stock.
CY2024Q2 GTCH Convertible Note Payable To Stanley Hills
ConvertibleNotePayableToStanleyHills
491395 usd
CY2023Q4 GTCH Convertible Note Payable To Stanley Hills
ConvertibleNotePayableToStanleyHills
661395 usd
CY2024Q2 GTCH Unamortized Debt Discount At Convertible Note Payable
UnamortizedDebtDiscountAtConvertibleNotePayable
0 usd
CY2023Q4 GTCH Unamortized Debt Discount At Convertible Note Payable
UnamortizedDebtDiscountAtConvertibleNotePayable
0 usd
CY2024Q2 GTCH Other Convertible Notes Payable Current
OtherConvertibleNotesPayableCurrent
491395 usd
CY2023Q4 GTCH Other Convertible Notes Payable Current
OtherConvertibleNotesPayableCurrent
661395 usd
CY2024Q2 GTCH Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-491395 usd
CY2023Q4 GTCH Less Current Portion Of Convertible Note Payable
LessCurrentPortionOfConvertibleNotePayable
-661395 usd
CY2024Q2 GTCH Convertible Notes Payable Net Related Party Longterm Portion
ConvertibleNotesPayableNetRelatedPartyLongtermPortion
0 usd
CY2023Q4 GTCH Convertible Notes Payable Net Related Party Longterm Portion
ConvertibleNotesPayableNetRelatedPartyLongtermPortion
0 usd
CY2024Q2 GTCH Total Notes Payables
TotalNotesPayables
350000 usd
CY2023Q4 GTCH Total Notes Payables
TotalNotesPayables
377546 usd
CY2024Q2 GTCH Debt Instruments Unamortized Discount Current
DebtInstrumentsUnamortizedDiscountCurrent
0 usd
CY2023Q4 GTCH Debt Instruments Unamortized Discount Current
DebtInstrumentsUnamortizedDiscountCurrent
-2265 usd
CY2024Q2 GTCH Note Payables
NotePayables
350000 usd
CY2023Q4 GTCH Note Payables
NotePayables
375281 usd
CY2024Q2 GTCH Current Portion Of Notes Payables
CurrentPortionOfNotesPayables
-21252 usd
CY2023Q4 GTCH Current Portion Of Notes Payables
CurrentPortionOfNotesPayables
-46533 usd
CY2024Q2 GTCH Long Term Note Payables
LongTermNotePayables
328748 usd
CY2023Q4 GTCH Long Term Note Payables
LongTermNotePayables
328748 usd
GTCH Schedule Of Note Payable Related Parties Table Textblock
ScheduleOfNotePayableRelatedPartiesTableTextblock
<table cellpadding="0" cellspacing="0" id="xdx_892_ecustom--ScheduleOfNotePayableRelatedPartiesTableTextblock_zy82ONXTpA53" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Notes Payable, Non-related Parties and Related Party (Details 1)"> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt"><span id="xdx_8B9_zYxwNgyEM718" style="display: none">Schedule of notes payable, related parties</span></td> <td> </td> <td colspan="3" style="text-align: center"> </td> <td> </td> <td colspan="3" style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td> </td> <td colspan="3" style="text-align: center">June 30,</td> <td> </td> <td colspan="3" style="text-align: center">December 31,</td></tr> <tr style="vertical-align: bottom"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: center; text-indent: -10pt"> </td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2024</td> <td style="padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; text-align: center">2023</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; width: 56%; text-align: left; text-indent: -10pt">Alpha Eda Note payable</td> <td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td> <td id="xdx_988_ecustom--TotalNotesPayableRelatedParty_iI_pp0p0_c20240630__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zgeTUwvnELN3" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td> <td style="width: 8%; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; width: 1%; text-align: left">$</td> <td id="xdx_98E_ecustom--TotalNotesPayableRelatedParty_pp0p0_c20231231__us-gaap--BusinessAcquisitionAxis__custom--AlphaEdaMember_zFLccvamCA0e" style="border-bottom: Black 1pt solid; width: 12%; text-align: right" title="Total notes payable, related party">140,000</td> <td style="width: 1%; padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Total notes payable, related party</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98B_ecustom--TotalNotesPayableRelatedParties_iI_pp0p0_c20240630_zVJyWRFP7dPi" style="text-align: right" title="Total notes payable, related party">140,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_981_ecustom--TotalNotesPayableRelatedParties_iI_pp0p0_c20231231_zL86RRbWojQk" style="text-align: right" title="Total notes payable, related party">140,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Unamortized debt discount</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_981_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_d0_c20240630_zIayJID9s4If" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_98D_ecustom--DebtInstrumentsUnamortizedDiscountCurrents_iI_pp0p0_d0_c20231231_zSv216V5VHL3" style="border-bottom: Black 1pt solid; text-align: right" title="Unamortized debt discount">—</td> <td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98A_ecustom--NotesPayableRelatedParties_iI_pp0p0_c20240630_zj5vWrK4Mcda" style="text-align: right" title="Notes payable, net, related party">140,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_982_ecustom--NotesPayableRelatedParties_pp0p0_c20231231_zwRF7ElJyFQh" style="text-align: right" title="Notes payable, net, related party">140,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Less current portion</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_981_ecustom--CurrentPortionOfNotePayableRelatedParties_iI_pp0p0_c20240630_zQDE4MXLDmnh" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td> <td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td> <td id="xdx_986_ecustom--CurrentPortionOfNotePayableRelatedParties_pp0p0_c20231231_zwvLoabFCxSh" style="border-bottom: Black 1pt solid; text-align: right" title="Less current portion">(140,000</td> <td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding: 0pt 0pt 0pt 10pt; text-align: left; text-indent: -10pt">Notes payable, net, related party, long-term portion</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98B_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_d0_c20240630_zGIwpbG2Q73c" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98E_ecustom--NotesPayableNetRelatedPartyLongtermPortion_iI_pp0p0_d0_c20231231_zIhOyIfgZ54j" style="border-bottom: Black 2.5pt double; text-align: right" title="Notes payable, net, related party, long-term portion">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>
CY2024Q2 GTCH Total Notes Payable Related Parties
TotalNotesPayableRelatedParties
140000 usd
CY2023Q4 GTCH Total Notes Payable Related Parties
TotalNotesPayableRelatedParties
140000 usd
CY2024Q2 GTCH Debt Instruments Unamortized Discount Currents
DebtInstrumentsUnamortizedDiscountCurrents
0 usd
CY2023Q4 GTCH Debt Instruments Unamortized Discount Currents
DebtInstrumentsUnamortizedDiscountCurrents
0 usd
CY2024Q2 GTCH Notes Payable Related Parties
NotesPayableRelatedParties
140000 usd
CY2023Q4 GTCH Notes Payable Related Parties
NotesPayableRelatedParties
140000 usd
CY2024Q2 GTCH Current Portion Of Note Payable Related Parties
CurrentPortionOfNotePayableRelatedParties
-140000 usd
CY2023Q4 GTCH Current Portion Of Note Payable Related Parties
CurrentPortionOfNotePayableRelatedParties
-140000 usd
CY2024Q2 GTCH Notes Payable Net Related Party Longterm Portion
NotesPayableNetRelatedPartyLongtermPortion
0 usd
CY2023Q4 GTCH Notes Payable Net Related Party Longterm Portion
NotesPayableNetRelatedPartyLongtermPortion
0 usd
CY2024Q2 GTCH Accrued Settlement Payable
AccruedSettlementPayable
4090057 usd
CY2023Q4 GTCH Accrued Settlement Payable
AccruedSettlementPayable
4090057 usd
CY2024Q2 GTCH Accrued Settlement
AccruedSettlement
4090057 usd
CY2023Q4 GTCH Accrued Settlement
AccruedSettlement
4090057 usd
CY2024Q2 GTCH Accrued Settlement
AccruedSettlement
4090057 usd
CY2023Q4 GTCH Accrued Settlement
AccruedSettlement
4090057 usd
CY2024Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0001
CY2023Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
0.0002
CY2024Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.000085
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
14116062 usd
us-gaap Fair Value Net Derivative Asset Liability Measured On Recurring Basis Unobservable Inputs Reconciliation Issues
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues
0 usd
GTCH Fair Value Of Beneficial Conversion Feature Of Debt Converted
FairValueOfBeneficialConversionFeatureOfDebtConverted
694919 usd
GTCH Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Los
FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLos
-8750797 usd
CY2024Q2 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4670346 usd
CY2023Q4 us-gaap Share Price
SharePrice
0.0002
CY2024Q2 us-gaap Share Price
SharePrice
0.0001
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000000 shares
us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
6559534118 shares
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
555680 usd
GTCH Debt Conversion Converted Instrument Accrued Interest
DebtConversionConvertedInstrumentAccruedInterest
1880 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
16813229180 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
16813229180 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
10253695062 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
10253695062 shares
CY2024Q2 GTCH Treasury Shares Issued
TreasurySharesIssued
8 shares
CY2023Q4 GTCH Treasury Shares Issued
TreasurySharesIssued
8 shares
CY2024Q2 us-gaap Treasury Stock Value
TreasuryStockValue
11059 usd
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
11059 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400 shares
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1595
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
400 shares
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
1595
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P0Y7D
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
400 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1595
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P0Y7D
CY2024Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0 usd
us-gaap Loss Contingency Disclosures
LossContingencyDisclosures
<p id="xdx_80F_eus-gaap--LossContingencyDisclosures_zZmRlHI5kc1g" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 16 - <span id="xdx_82E_zbrC6FH3wTTh">Contingencies</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>GBT Technologies, S.A.</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On September 14, 2018, the Company entered into an Exclusive Intellectual Property License and Royalty Agreement (the “GBT License Agreement”) with GBT-CR, a fully compliant and regulated crypto currency exchange platform that currently operates in Costa Rica as a decentralized crypto currency platform, pursuant to which, among other things, the Company granted to GBT-CR an exclusive, royalty-bearing right and license relating intellectual property relating to systems and methods of converting electronic transmissions into digital currency as reflected in that certain patent filed with the United Stated Patent and Trademark Office on or about June 14, 2018 (EFS ID: 32893586; Application Number: 16008069; Type: Utility under 35 USC 111(a); Confirmation Number: 6787)(collectively, the “Digital Currently Technology”). Pursuant to the GBT License Agreement, the Company granted GBT-CR an exclusive worldwide license to use the Digital Currency Technology to make, use, sell, lease or otherwise commercialize and dispose of products and devices utilizing the Digital Currently Technology. Under the terms of the GBT License Agreement, the Company is entitled to receive a royalty payment of 2% of gross revenue of each licensed product sold by GBT-CR during the period starting in which revenue is first generated using the licensed products and continuing for five years thereafter. Upon signing the GBT-CR License Agreement, GBT-CR paid the Company $<span id="xdx_900_eus-gaap--Revenues_c20180913__20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zUii5BbQsv9j" title="Revenues">300,000 </span>which is nonrefundable. The Company recognized the $<span id="xdx_908_eus-gaap--Revenues_c20180101__20181231__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zO0h78S0GI3k" title="Revenues">300,000</span> as revenue during the years ended December 31, 2018. Upon GBT-CR making available for sale (the “Commercial Event”) an ICO (Initial Coin Offering) (the “Coin”), GBT-CR will make a payment to the Company of $<span id="xdx_902_ecustom--PaymentForExpenses_c20180913__20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zim7nONwRKhj" title="Payment for expenses">5,000,000</span>. Further, upon the Commercial Event, GBT-CR will grant the Company the ability to acquire 30% of the Coin at a 30% discount of such offering price of the Coin. The GBT License Agreement commenced as of the signing date and, unless terminated in accordance with the termination provisions of the GBT License Agreement, shall remain in force until the expiration of the patent pertaining to the Digital Currency Technology; provided that the right to use trade secrets shall survive the expiration of the GBT License Agreement provided the Company has not terminated. Prior to the signing of the GBT License Agreement, GBT-CR advanced $<span id="xdx_901_eus-gaap--DeferredRevenue_iI_c20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zZZ6shlniuTe" title="Unearned revenue">200,000 </span>to the Company, which the parties have agreed will be applied toward the $<span id="xdx_904_ecustom--DueToRelatedPartyFees_iI_c20180914__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zu1P9VR5XQF7" title="Due to related party fees">5,000,000</span> fee when it becomes due. On February 27, 2020 GBT Technologies, S.A., as successor in interest to Hermes Roll, LLC had notified the Company that it was in default on its Amended and Restated Territorial License Agreement (“ARTLA”) dated June 15, 2015 and that the ARTLA had been cancelled and rescinded.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><i>Stock Loan Receivable</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On January 8, 2019, the Company entered into a Stock Pledge Agreement with Latin American Exchange Latinex Casa de Cambio, S.A., a Costa Rica corporation (“Latinex”), to provide that Latinex may maintain its required regulatory capital as required by various regulators. The Company pledged <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_z1VDJUH83RYh" title="Restricted shares">4,006</span> restricted shares of its common stock valued at $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueRestrictedStockAwardGross_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_z0MBkF4P31Df" title="Value of restricted shares">7,610,147</span> (based on the closing price on the grant date) for three years for an annual payment of $<span id="xdx_90C_ecustom--AnnualPayment_iI_c20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zMciaPOIA5dc" title="Annual payment">375,000 </span>paid in quarterly installments of $93,750. In lieu of cash payment, Latinex may pay the Company in virtual currency of WISE Network S.A. valued at a 50% discount of its offering price of $10 per token. In the event that Latinex’s required capital has decreased below $<span id="xdx_909_ecustom--DecreaseInCapital_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zHJr1pXFCD4f" title="Decrease in capital">5,000,000</span>, Latinex is permitted to sell the pledged shares of common stock only in an amount to ensure that Latinex can satisfy the required capital levels. The Company must consent to such sale of the shares of common stock, which may not be unreasonably withheld. Upon expiration of the agreement, the remaining shares of common stock shall be returned to the Company free and clear of all liens. The Company recorded the value of these shares of common stock as a stock loan receivable which is presented as a contra-equity account in the accompanying consolidated balance sheets. At December 31, 2019, the Company wrote off the accrued interest income as Latinex did not perform any payment and the Company has no mean to enforce this payment. Latinex agreed in principle to return the pledged <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardForfeited_c20190107__20190108__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_zNMTVU09svH6" title="Cancellation of restricted shares">4,006</span> restricted shares to the Company for cancellation. The <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesRestrictedStockAwardGross_c20230101__20231231__us-gaap--TypeOfArrangementAxis__custom--StockPledgeAgreementMember_ztE8bSoHigVa" title="Restricted shares">4,006</span> restricted shares have not yet been returned to the Company as of June 30, 2024.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Metaverse Agreements</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 10, 2022, the Company, entered into a Joint Venture and Territorial License Agreement (the “Metaverse Agreement”) with Ildar Gainulin and Maria Belova (collectively, the “Licensor”). Under the Metaverse Agreement, the parties formed Metaverse Kit Corp., a Nevada corporation (“Metaverse Kit”). The purpose of Metaverse Kit was to develop, maintain and support source codes for its proprietary technologies and comprehensive platform that combines a core virtual reality platform and an extended set of real-world functions to provide a metaverse experience initially within the area of sports and then expanding into virtual worlds of entertainment, live events, gaming, communications and other cross over product opportunities (the “Meta Portfolio”). Under the Metaverse Agreement, Licensor agreed to provide Metaverse Kit with the licensed technology and expertise. In connection therewith, the parties entered an Asset Purchase Agreement (the “Metaverse APA”) concurrently with the Metaverse Agreement whereby Licensor sold Metaverse Kit all source codes pertaining to the Meta Portfolio. Further, Licensor provided an exclusive license to Metaverse Kit throughout the world for the invented product/service and the related platforms relating to the Meta Portfolio and to use the know how to develop, manufacture, sell, market and distribute the Meta Portfolio throughout the world. The Company was required to contribute <span id="xdx_90A_eus-gaap--SharesIssued_iI_c20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementsMember_zVcs17RUIJa4" title="Share issued">500,000,000</span> shares of common stock of the Company (“GBT Shares”) to Metaverse Kit. Licensor and the Company were to each own 50% of Metaverse Kit. The Company pledged its <span id="xdx_90D_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20220610__us-gaap--TypeOfArrangementAxis__custom--MetaverseAgreementsMember_zg0DFSaC6wj1" title="Ownership percentage">50</span>% ownership in Metaverse Kit to Igor 1 Corp. to secure a convertible note held by Igor 1 Corp. The Company was to appoint two directors and Licensor was allowed to appoint one director of Metaverse Kit. In addition, Metaverse Kit, Licensor and Elentina Group, LLC (“Elentina”) entered into a Consulting Agreements in which IGBM and Elentina, each were engaged to provide services for $<span id="xdx_909_ecustom--PaymentForServices_c20220609__20220610__us-gaap--TypeOfArrangementAxis__custom--ConsultingAgreementsMember_zTjQRjtBssT8" title="Payment for services">25,000</span> per month payable quarterly which Metaverse Kit has the option to pay in shares of common stock calculated by the amount owed divided by the Company’s 10-day VWAP. Licensor and Elentina were to provide services in connection with the development of the business as well as Metaverse Kit’s capital raising efforts. The term of the Consulting Agreement was two years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">The closing of the Metaverse Agreement occurred on June 13, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On March 14, 2023, the Company received a counter signed Settlement Agreement and Release by Licensor dated March 2, 2023 (“Settlement Agreement”). Pursuant to the Settlement Agreement, the parties agreed that Metaverse Agreement, the Metaverse APA and the Consulting Agreement are void and cancelled. Licensor agreed to pay $<span id="xdx_909_ecustom--PaymentForSettlement_c20230313__20230314__us-gaap--TypeOfArrangementAxis__custom--SettlementAgreementMember_zMSAKx5ysmj3" title="Payment for settlement">5,000</span> to the Company as settlement payment and surrender their shares in Metaverse Kit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On February 1, 2023, the Company engaged AlKhatib Consulting Group to provide exclusive representation services in connect with managing market partners, effective on February 1, 2023 for 24 consecutive months till 2025.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Assets Sale - TREN</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 3, 2023, GBT Tokenize Corp. (“Seller”), a subsidiary that is owned <span id="xdx_900_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230403__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zc8SOYNrpSne" title="Ownership percentage">50</span>% by the Company, entered into an agreement to sell certain assets relating to a proprietary system and method named Avant-Ai to TREN. Avant-Ai is a text-generation, deep learning self-training model. In exchange for the assets, TREN is required to issue <span id="xdx_90B_ecustom--NumberOfSharesSold_iI_c20230403__dei--LegalEntityAxis__custom--GBTTechnologiesMember_zO9df03iJqx2" title="Number of shares sold">26,000,000</span> common shares (“Shares”) to Seller.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On July 18, 2023, TREN changed its name to Avant Technologies, Inc. and its ticker symbol on OTC Markets was changed to AVAI.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Potential IP’s Sale</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On April 17, 2023, Bannix Acquisition Corp. (“Bannix”), EVIE Autonomous Group Ltd. (“EVIE”) and EVIE’s shareholders entered into a Business Combination Agreement pursuant to which Bannix agreed to acquire EVIE. In addition, Bannix agreed to acquire from GBT Technologies Inc. (the “Company” or “GBT”), the Apollo System which is intellectual property covered by patent application filed with the US Patent and Trademark Office. This patent application describes a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and moving objects. The Apollo system is based on radio waves and can detect an entity’s moving and stationary positions, enabling imaging technology to show these movements and positions on a screen in real time. This includes an AI technology that controls the radio waves transmission and analyzes the reflections. The goal is to integrate the Apollo System as an efficient driver monitoring system, detecting impaired or distracted drivers, providing audible and visual alerts (“the “Patents”). On August 8, 2023, Bannix entered into a Patent Purchase Agreement (“PPA”) with GBT Tokenize Corp. (“Tokenize”), which is <span id="xdx_909_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230808__dei--LegalEntityAxis__custom--PatentPurchaseAgreementMember__srt--OwnershipAxis__custom--TokenizeMember_zCu024hkhtJf" title="Ownership percentage">50</span>% owned by GBT, where GBT provided its consent, to acquire the entire right, title, and interest of the Patents. The closing date of the PPA will be immediately follow the closing of the acquisition of EVIE by Bannix. The Purchase Price is set at 5% of the consideration that Bannix is paying to the shareholders of EVIE. The Business Combination Agreement sets the consideration to be paid by Bannix at $<span id="xdx_905_eus-gaap--BusinessCombinationConsiderationTransferred1_pn6n6_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--BannixMember_zgVy3CiL55ve" title="Business combination consideration paid">850</span> million and, in turn, the consideration in the PPA to be paid to Tokenize is $<span id="xdx_90A_eus-gaap--BusinessCombinationConsiderationTransferred1_pn5n6_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_zZa3EwqUNie" title="Business combination consideration paid">42.5</span> million. If the final purchase price is less than $<span id="xdx_90B_eus-gaap--BusinessCombinationPriceOfAcquisitionExpected_pn6n6_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_zEmxRYi2eWna" title="Business combination purchase price">30</span> million, Tokenize has the option to cancel the PPA.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance therewith, Bannix agrees to pay, issue and deliver to Tokenize, $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zioUmH0FmB88" title="Number of shares issued, value">42,500,000</span> in series A preferred stock to Tokenize, which such terms will be more fully set forth in the Series A Preferred Stock Certificate of Designation to be filed with the Secretary of State of the State of prior to the Closing Date. The Series A Preferred Stock will have stated value of face value of $<span id="xdx_908_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zgzi25kc6cZ5" title="Preferred stock, par value">1,000</span> per share and is convertible, at the option of Tokenize, into shares of common stock of Bannix at 5% discount to the VWAP during the 20 trading days prior to conversion, and in any event not less than $<span id="xdx_90B_eus-gaap--SharePrice_iI_c20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z71FVc7idDdh" title="Share price">1.00</span>. The Series A Preferred Stock will not have voting rights and will be entitled to dividends only in the event of liquidation. The Series A Preferred Stock will have a <span id="xdx_90F_eus-gaap--VariableInterestEntityOwnershipPercentage_dp_c20230807__20230808__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zK6MDifshULb" title="Beneficial ownership limitation">4.99</span>% beneficial ownership limitation. Series A Preferred Stock and the shares of common stock issuable upon conversion of the Series A Preferred Stock (the “Conversion Shares”) shall be subject to a lock-up beginning on the Closing Date and ending on the earliest of (i) the six (6) months after such date, (ii) a Change in Control, or (iii) written consent of Purchaser (the “Seller Lockup Period”)</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On December 18, 2023, Bannix and Tokenize entered into Amendment No. 1 to the PPA. Per the amendment, Bannix and Tokenize agreed that the shares of common stock to be issued upon conversion of the Series A Preferred Stock will not exceed 19.99% of the aggregate number of shares of common stock issued and outstanding as of the closing of Bannix’s acquisition of EVIE (such maximum number of shares, the “<span style="text-decoration: underline">Exchange Cap</span>”) unless Bannix’s stockholders have approved the issuance of shares of common stock upon conversion of the Series A Preferred Stock pursuant to the PPA in excess of the Exchange Cap in accordance with the applicable rules of the market or exchange on which Bannix’s shares of common stock trade.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838">On March 11, 2024, Bannix sent EVIE and the shareholder of EVIE a notice providing that the BCA has been terminated (“BNIX EVIE Termination Letter”). As the PPA was contingent upon Bannix closing the acquisition of the EVIE and due to the BNIX EVIE Termination Letter, on March 19, 2024 Bannix and Tokenize agreed to terminate the PPA which was consented to by the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">Effective as of March 20, 2024, Tokeniz, entered into a Patent Purchase Agreement with VisionWave Technologies Inc. (“VisionWave”) pursuant to which VisionWave agreed to acquire from Tokenize the entire right, title, and interest of certain patents and patent applications providing an intellectual property basis for a machine learning driven technology that controls radio wave transmissions, analyzes their reflections data, and constructs 2D/3D images of stationary and in motion objects (“VisionWave PPA”).</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838">The Purchase Price for the asset is $<span id="xdx_906_ecustom--PurchasePrice_c20240319__20240320__us-gaap--LongtermDebtTypeAxis__custom--VisionWaveMember_zFEkvjRIOET9" title="Purchase price">30,000,000</span> (the “Purchase Price”), which VisionWave will pay with shares of common stock, $0.0001 par value per share (the “Common Stock”). The Parties agree that the final Purchase Price may be adjusted and will be governed by a valuation report issued by a professional third party (“Valuation”). If the final Purchase Price per Valuation is less than $<span id="xdx_908_ecustom--PurchasePrice_c20240319__20240320__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_zQUG7uyOwdcj" title="Purchase price">30,000,000</span>, Tokenize has the option to cancel this Agreement. In accordance therewith, VisionWave agreed to issue and deliver to Tokenize, 1,000 shares of Common Stock (the “Shares”) representing 50% of VisionWave’s issued and outstanding shares of Common Stock, where the remainder of the 50% of VisionWave’s issued and outstanding shares of Common Stock are owned by a corporation controlled by Stanley Hills. Effective June 4, 2024 Tokenize been issued additional 222 shares from VisionWave for consideration of 10 million AVAI shares that been vested under VisionWave name.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; color: #1D2838"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Service Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 24, 2023, the Company entered into a service agreement with Pacific Capital Markets LLC, where <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCapitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zwxAukNobNY6" title="Number of shares issued, shares">100,000,000</span> Shares issued to it for certain for service agreement between Pacific Capital Markets LLC. and the Company. The value of the shares of $<span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20230223__20230224__dei--LegalEntityAxis__custom--PacificCapitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zd4EFHDKfMgb" title="Number of shares issued, value">80,000</span> was determined based on the stock price of the Company’s common stock at grant date of $<span id="xdx_90D_ecustom--GrantPerShare_iI_c20230224__dei--LegalEntityAxis__custom--PacificCapitalMarketsLLCMember__us-gaap--TypeOfArrangementAxis__custom--ServiceAgreementMember_zBG8mCWF33u5" title="Grant per share">0.0008</span> per share.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Representation Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 17, 2023, Tokenize, which is <span id="xdx_90E_ecustom--MinorityInterestsOwnershipPercentageByParent_iI_dp_c20230817__us-gaap--BusinessAcquisitionAxis__custom--TokenizeMember_zn9EVP7RnJy1" title="Ownership percentage">50</span>% owned of the Company, which provided its consent, entered into a Representation Agreement (the ‘RA’) with IDL Concepts, LLC (the ‘Agent’) , to represent Tokenize in a potential purchase transaction facilitated by the Agent transferring all of Tokenize’s right, title, and interest in certain Assigned Patent Rights, as defined in the RA, free and clear of any restrictions, liens, claims, and encumbrances, and may include rights to technology and software developed by Tokenize. Tokenize owns certain provisional patent applications, patent applications, patents, and/or related foreign patents and applications, and wishes potentially to sell all right, title, and interest in such patents and applications and the causes of action to sue for infringement thereof and other enforcement rights. Tokenize will pay Agent a commission of 20% of any proceeds of any closed transaction under this RA, including all cash, equity payments and any other form of consideration upon a sale, or any monetization activity under the RA. The RA carved out certain intellectual properties held by Tokenize that Tokenize is in active negotiation with third parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-307775556 usd
CY2024Q2 GTCH Working Capital Deficits
WorkingCapitalDeficits
22323432 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001731122-24-001273-index-headers.html Edgar Link pending
0001731122-24-001273-index.html Edgar Link pending
0001731122-24-001273.txt Edgar Link pending
0001731122-24-001273-xbrl.zip Edgar Link pending
e5834_10-q.htm Edgar Link pending
e5834_ex31-1.htm Edgar Link pending
e5834_ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gtch-20240630.xsd Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
gtch-20240630_cal.xml Edgar Link unprocessable
gtch-20240630_def.xml Edgar Link unprocessable
gtch-20240630_lab.xml Edgar Link unprocessable
gtch-20240630_pre.xml Edgar Link unprocessable
e5834_10-q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending